fda compounding glp 1 Compounded GLP-1s are entering a new phase of scrutiny. With the targeting large-scale compounded GLP-1 manufacturing, patients are facing a moment where access, safety, and regulatory clarity all matter. In my Compounded Semaglutide & Tirzepatide 2025:

This is a common concern

Microdosing of GLP-1's The Rationale for Microdosing While GLP-1 receptor agonists (GLP-1 RAs) are effective treatments, higher doses can cause gastrointestinal side effects such as nausea and vomiting

Expected Results by Week Quantified Results from Research Available research provides some quantified expectations for GHK-CU results

Notably, research exploring combinations of GHRH analogs and GHRP-2 observed more pronounced increases in pulsatile GH secretion than with either peptide alone, suggesting potential synergistic interactions

Front Nutr 10:1179432

Plus, LL-37 could be protumorigenicmeaning it could cause tumors to developin some tissues